REGORAFENIB

Clinical trials for REGORAFENIB explained in plain language.

Never miss a new study

Get alerted when new REGORAFENIB trials appear

Sign up with your email to follow new studies for REGORAFENIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug cocktail aims to wipe out hidden colorectal cancer cells

Disease control Terminated

This phase 2 trial tests two drugs, regorafenib and lorigerlimab, in people with high-risk colorectal cancer who have no visible tumors but still have cancer DNA in their blood after standard treatment. The goal is to see if the combination can clear these hidden cancer cells and…

Matched conditions: REGORAFENIB

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 13:02 UTC

REGORAFENIB

Get alerted when new REGORAFENIB trials appear

New drug cocktail aims to wipe out hidden colorectal cancer cells